CytoMed Therapeutics Statistics

Total Valuation

GDTC has a market cap or net worth of $10.65 million. The enterprise value is $9.40 million.

Market Cap	10.65M
Enterprise Value	9.40M

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

GDTC has 11.83 million shares outstanding. The number of shares has increased by 0.93% in one year.

Current Share Class	11.83M
Shares Outstanding	11.83M
Shares Change (YoY)	+0.93%
Shares Change (QoQ)	+1.86%
Owned by Insiders (%)	16.78%
Owned by Institutions (%)	0.49%
Float	3.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.91
Forward PS	n/a
PB Ratio	2.09
P/TBV Ratio	2.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.07.

Current Ratio	5.17
Quick Ratio	3.14
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-202.49

Financial Efficiency

Return on equity (ROE) is -50.28% and return on invested capital (ROIC) is -31.42%.

Return on Equity (ROE)	-50.28%
Return on Assets (ROA)	-29.31%
Return on Invested Capital (ROIC)	-31.42%
Return on Capital Employed (ROCE)	-58.18%
Weighted Average Cost of Capital (WACC)	3.10%
Revenue Per Employee	$15,565
Profits Per Employee	-$71,969
Employee Count	43
Asset Turnover	0.10
Inventory Turnover	0.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.53% in the last 52 weeks. The beta is -0.21, so GDTC's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-60.53%
50-Day Moving Average	1.03
200-Day Moving Average	1.58
Relative Strength Index (RSI)	34.92
Average Volume (20 Days)	6,697

Short Selling Information

The latest short interest is 71,945, so 0.61% of the outstanding shares have been sold short.

Short Interest	71,945
Short Previous Month	82,681
Short % of Shares Out	0.61%
Short % of Float	1.81%
Short Ratio (days to cover)	9.27

Income Statement

In the last 12 months, GDTC had revenue of $669,280 and -$3.09 million in losses. Loss per share was -$0.27.

Revenue	669,280
Gross Profit	599,495
Operating Income	-3.29M
Pretax Income	-3.11M
Net Income	-3.09M
EBITDA	-2.99M
EBIT	-3.29M
Loss Per Share	-$0.27

Full Income Statement

Balance Sheet

The company has $1.63 million in cash and $375,176 in debt, giving a net cash position of $1.25 million or $0.11 per share.

Cash & Cash Equivalents	1.63M
Total Debt	375,176
Net Cash	1.25M
Net Cash Per Share	$0.11
Equity (Book Value)	5.33M
Book Value Per Share	0.43
Working Capital	2.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.87 million and capital expenditures -$495,907, giving a free cash flow of -$3.39 million.

Operating Cash Flow	-2.87M
Capital Expenditures	-495,907
Depreciation & Amortization	300,361
Net Borrowing	-41,919
Free Cash Flow	-3.39M
FCF Per Share	-$0.29

Full Cash Flow Statement

Margins

Gross Margin	89.57%
Operating Margin	-491.75%
Pretax Margin	-464.23%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.93%
Shareholder Yield	-0.93%
Earnings Yield	-29.06%
FCF Yield	-31.87%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GDTC has an Altman Z-Score of 13.12 and a Piotroski F-Score of 3.

Altman Z-Score	13.12
Piotroski F-Score	3